To identify the number of people being treated for diabetes, cancer, and heart disease in North America, Europe, and Australasia and including demographic information and private/public expenditure per capita.
Diabetes: North America
- According to the International Diabetes Federation (IDF), the prevalence of Diabetes in North America (including the Caribbean) is 11.1% in 2019. Around 48 million people have Diabetes in this region.
- The number of people living with Diabetes in 3 (out of 23) countries in the North American region are as follows.
- The IDF further states that 37.8% of adults living with diabetes are undiagnosed. From this we can assume that 62.2% (100-37.8) of the population with Diabetes are receiving treatment.
- Based on the above information, we can conclude that around 29.9 million people (48 million*62.2%) with Diabetes are receiving treatment in the North American region.
- According to the IDF, the highest prevalence of Diabetes is seen in males, aged 70-79 (page 71).
Spending on Treatment
- in 2019, USD 324.5 billion was spent on diabetes in North America (and Caribbean), which was higher than any other region in the world and corresponds to 42.7% of the total global health
expenditure on Diabetes.
- USD 294.6 billion was spent
on Diabetes in the United States during 2019 and also has the highest mean expenditure per person in the region with USD 9,506, followed by Canada
(USD 4,397). The lowest in the Region was Haiti (USD 142).
For the purpose of scoping the remaining project, we have identified the number of countries in each region to be as follows:
Proposed next steps:
You need to be the project owner to select a next step.
We will continue this research for the remaining regions: EU and Australasia. For each region, we will focus on the following criteria: 1) the number of people living with diabetes, cancer, and heart disease and 2) the demographic distribution (age, gender) and private/public expenditure per person being treated for each disease (Note: a single request covers 1 region and 1 disease).
We will also provide the remaining information that was not identified in the initial research for North America: a breakdown of the population being treated for Diabetes based on age and gender, and public and private expenditure per capita for treatment of the disease.
Note: please let us know if the private and public expenditure per person should be identified separately. If it is a combined total, both demographics and expenditure can be covered in 1 request.
For 10 countries in each region, we will identify the number of people being treated for diabetes, cancer, and heart disease in North America, Europe, and Australasia and private/public expenditure (combined) per person (a single request covers 5 countries and 1 disease). Let us know if you need us to adjust the number of countries to cover.